The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Market Size Is Forecasted For The Gene Delivery Technologies Market By 2030 Based On Its 2026 Value?
The gene delivery technologies market has experienced swift expansion in recent years. This market is set to increase from $4.29 billion in 2025 to $4.92 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.7%. Historically, this growth can be ascribed to factors such as an escalation in gene therapy research, the evolution of viral vectors, consistent academic research funding, the adoption of electroporation techniques, and numerous vaccine development programs.
The gene delivery technologies market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $8.46 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.5%. This growth throughout the forecast period is fueled by the expansion of gene therapy pipelines, continuous innovation in delivery vectors, the demand for safer delivery methods, an increase in cell therapy applications, and heightened clinical trial activity. Prominent trends anticipated in the forecast period include the increasing use of viral and non-viral delivery systems, wider adoption in gene and cell therapy, the proliferation of lipid nanoparticle technologies, a growing emphasis on targeted gene delivery, and advancements in physical gene transfer methods.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10706&type=smp
Which Growth Drivers Are Expected To Support The Gene Delivery Technologies Market Forward?
The increasing number of cell and gene therapies is projected to propel the expansion of the gene delivery technologies market going forward. Cell and gene therapies are medical treatments designed to alleviate or cure diseases by modifying a patient’s genetic and cellular composition. The escalating volume of cell and gene therapies is predominantly fueled by advancements in gene editing technologies, which are instrumental in their development and commercialization. As an illustration, IQVIA, a US-based provider of advanced analytics, technology solutions, and contract research services, reported in March 2025 that new CAR T trial starts reached 199 in 2024, while gene therapy trial starts totaled 130; these statistics represented increases of 54% and 65%, respectively. Consequently, the rise in cell and gene therapies drives the gene delivery technologies market.
Which Segment Divisions Form The Structure Of The Gene Delivery Technologies Market?
The gene delivery technologies market covered in this report is segmented –
1) By Mode: Biological, Chemical, Physical
2) By Method: Ex Vivo, In Vivo, In Vitro
3) By Application: Gene Therapy, Cell Therapy, Vaccines, Research
Subsegments:
1) By Biological: Viral Vectors, Bacterial Vectors, Lipid Nanoparticles
2) By Chemical: Cationic Lipids, Polymers, Chemical Transfection Agents
3) By Physical: Electroporation, Microinjection, Gene Gun, Sonoporation
What Trends Are Affecting The Gene Delivery Technologies Market Dynamics?
Major companies involved in gene delivery technologies are prioritizing the development of sophisticated products, like ProteoAnalyzer, to gain a competitive edge in the market. The ProteoAnalyzer is an advanced automated system from Agilent Technologies for protein analysis, specifically utilizing parallel capillary electrophoresis (CE) technology. For instance, in July 2024, Agilent Technologies Inc., a US-based life sciences company, launched the ProteoAnalyzer system. This innovative platform is engineered for automated parallel capillary electrophoresis (CE), enabling rapid, high-resolution protein analysis with minimal sample consumption. This capability is especially beneficial for researchers working with complex protein mixtures in pharmaceuticals, biopharma, and bioengineered food ingredients, facilitating faster discoveries and advancements in translational research. The system allows for a detailed examination of protein mixtures, which is crucial for the development of therapeutic proteins.
Which Organizations Are Involved In The Gene Delivery Technologies Market?
Major companies operating in the gene delivery technologies market are Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Catalent Inc., Pfizer Inc., Becton Dickinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Beam Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG
Access The Complete Gene Delivery Technologies Market Report:
https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report
Which Region Stands As The Largest Contributor To The Gene Delivery Technologies Market?
North America was the largest region in the gene delivery technologies market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Gene Delivery Technologies Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=10706&type=smp
Browse Through More Reports Similar to the Global Gene Delivery Technologies Market 2026, By The Business Research Company
Testosterone Replacement Therapy Global Market Report 2026
Male Hypogonadism Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report
Non Surgical Cosmetic Procedures Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
